APA (7th ed.) Citation

M, B., KV, M., MP, G., PL, R., E, R., & CD, A. (2014). Preclinical safety evaluation of human platelets treated with antimicrobial peptides in severe combined immunodeficient mice. Transfusion, 54(3), 569. https://doi.org/10.1111/trf.12318

Chicago Style (17th ed.) Citation

M, Bosch-Marcé, Mohan KV, Gelderman MP, Ryan PL, Russek-Cohen E, and Atreya CD. "Preclinical Safety Evaluation of Human Platelets Treated with Antimicrobial Peptides in Severe Combined Immunodeficient Mice." Transfusion 54, no. 3 (2014): 569. https://doi.org/10.1111/trf.12318.

MLA (9th ed.) Citation

M, Bosch-Marcé, et al. "Preclinical Safety Evaluation of Human Platelets Treated with Antimicrobial Peptides in Severe Combined Immunodeficient Mice." Transfusion, vol. 54, no. 3, 2014, p. 569, https://doi.org/10.1111/trf.12318.